vimarsana.com

Page 4 - தொழிற்சங்கம் அமைச்சர் கடுமையான வர்தன் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

COVID-19 vaccination drive suspended in Maharashtra till Monday due to Co-Win app glitches

Maharashtra halts Covid-19 vaccination drive till Monday due to Co-Win app glitches

Maharashtra halts Covid-19 vaccination drive till Monday due to Co-Win app glitches India Updated: Sunday, January 17, 2021, 0:13 [IST] New Delhi, Jan 16: Maharashtra government has decided to temporarily suspendCOVID19 vaccination till 18th January in the entire state due to technical issues with CoWIN App. The inoculation drive suffered minor setbacks on Day 1 at some places due to glitches in the CoWIN app. Representational Image The app has been created by the Centre for managing registration for the inoculation. Nationwide inoculation drive for coronavirus began on Saturday morning. Not just in Maharashtra, everywhere in the country this app created problems in the execution of vaccination drive. We have decided to suspend the vaccination for the next two days, Tope told PTI.

India taps Industry 4 0 revolution to boost blue economy

Indias marine scientific research capability has received a boost with the commissioning of coastal research vessel (CRV) Sagar Anveshika. The vessel joins the fleet of three other vessels of the same class Sagar Tara, Sagar Nidhi, and Sagar .

Harsh Vardhan reviews status of disease Kala Azar in four states

Harsh Vardhan reviews status of disease Kala Azar in four states ANI | Updated: Dec 30, 2020 20:43 IST New Delhi [India], December 30 (ANI): Union Minister Harsh Vardhan on Wednesday reviewed the status of the disease Kala-Azar in Uttar Pradesh, Bihar, Jharkhand and West Bengal. During an event held in presence of concerned officials from these fours states, the Union Health Minister asserted that the Government of India is strongly committed to the elimination of Kala Azar. Kala Azar is the 2nd largest parasitic killer in the world after Malaria and results in a 95 per cent fatality rate if the patients are not treated. Additionally, up to 20 per cent of the patients who are correctly treated and cured, develop a skin condition called Post-Kala-Azar Dermal Leishmaniasis (PKDL) which surfaces within months to years after treatment. These patients can contain large amounts of parasites in their skin lesions, making them an important sou

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.